Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?
Tapering glucocorticoids with 12.5 mg/day of prednisone equivalent could be a reasonable timepoint to initiate the withdrawal of PJP prophylaxis in patients with rheumatic diseases.
Authors
- Eun Bong Lee (ORCID: https://orcid.org/0000-0003-0703-1208)
- Se Rim Choi (ORCID: https://orcid.org/0000-0002-4625-8571)
- Jin Kyun Park (ORCID: https://orcid.org/0000-0003-2167-9393)
- Ju Yeon Kim (ORCID: https://orcid.org/0000-0001-8982-6869)
- Eun Young Lee (ORCID: https://orcid.org/0000-0001-6975-8627)
- Jun Won Park (ORCID: https://orcid.org/0000-0002-8624-2582)
Institutions
- Seoul National University (KR)
- New Generation University College (ET)
- Sungae Hospital (KR)
- Gwangmyeong Mental Health Welfare Center (KR)
- Hanyang University Seoul Hospital (KR)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1002/art.43167
- Citations
- 4
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- National Research Foundation
- National Research Foundation of Korea